Since qualifying in 2014, James has advised on a range of high-profile domestic and international transactions with a focus on M&A. His experience includes advising clients from startups to FTSE 100 companies on a variety of complex corporate and commercial matters, including technology commercialisation, private equity investments and joint ventures. He has also been seconded to work with the corporate and M&A team of a major international bank.

Download full bio 


  • Therachon Sells to Pfizer for up to $810 Million 

  • Bavarian Nordic Acquires Two Commercial Vaccines from GlaxoSmithKline for €796 Million 

  • Battery Ventures on its acquisition of Guardsquare 

  • RenalytixAI – £22 Million IPO 

  • Snyk acquires DeepCode 

  • View all


  • BPP University
    LPC, Distinction, 2012
    GDL, Distinction, 2011

  • King's College London
    BSc (Hons), Business Management, First Class, 2010

Admissions & Credentials

England & Wales